Priority Applications (16) Applications Claiming Priority (14) Publications (1) Family ID=74668840 Family Applications (2) Family Applications Before (1) Country Status (15) Cited By (1) Families Citing this family (14) Citations (6) Family Cites Families (458) 2021 2021-02-17 JP JP2022542471A patent/JP7761567B2/en active Active 2021-02-17 EP EP21706540.8A patent/EP4106724A1/en active Pending 2021-02-17 CA CA3165355A patent/CA3165355A1/en active Pending 2021-02-17 CN CN202511857532.1A patent/CN121868226A/en active Pending 2021-02-17 EP EP25154759.2A patent/EP4537848A3/en active Pending 2021-02-17 BR BR112022013746A patent/BR112022013746A2/en unknown 2021-02-17 US US17/799,700 patent/US12527844B2/en active Active 2021-02-17 US US17/800,747 patent/US20230093542A1/en active Pending 2021-02-17 AU AU2021208601A patent/AU2021208601B2/en active Active 2021-02-17 AU AU2021207313A patent/AU2021207313A1/en active Pending 2021-02-17 CA CA3304331A patent/CA3304331A1/en active Pending 2021-02-17 TW TW110105298A patent/TW202140063A/en unknown 2021-02-17 BR BR112022013795A patent/BR112022013795A2/en not_active Application Discontinuation 2021-02-17 PE PE2022001525A patent/PE20221575A1/en unknown 2021-02-17 PE PE2022001737A patent/PE20230819A1/en unknown 2021-02-17 US US17/177,438 patent/US11318191B2/en active Active 2021-02-17 IL IL294520A patent/IL294520A/en unknown 2021-02-17 JP JP2021544822A patent/JP7132441B2/en active Active 2021-02-17 TW TW110105296A patent/TWI878456B/en active 2021-02-17 CN CN202180015117.5A patent/CN115135305B/en active Active 2021-02-17 MX MX2022009523A patent/MX2022009523A/en unknown 2021-02-17 CN CN202180015533.5A patent/CN115135304B/en active Active 2021-02-17 KR KR1020227028398A patent/KR20220143037A/en active Pending 2021-02-17 KR KR1020227028397A patent/KR20220143036A/en active Pending 2021-02-17 WO PCT/EP2021/053805 patent/WO2021144476A1/en not_active Ceased 2021-02-17 MX MX2022009844A patent/MX2022009844A/en unknown 2021-02-17 TW TW114118279A patent/TW202535454A/en unknown 2021-02-17 CN CN202511857520.9A patent/CN121695079A/en active Pending 2021-02-17 CA CA3165359A patent/CA3165359A1/en active Pending 2021-02-17 WO PCT/EP2021/053809 patent/WO2021144477A1/en not_active Ceased 2021-02-17 EP EP21706537.4A patent/EP4106727A1/en active Pending 2021-02-17 CN CN202511191655.6A patent/CN121668282A/en active Pending 2021-02-17 CN CN202511192118.3A patent/CN121944081A/en active Pending 2021-02-17 IL IL294521A patent/IL294521A/en unknown 2021-02-17 CN CN202511190968.XA patent/CN121648259A/en active Pending 2022 2022-07-05 JP JP2022108371A patent/JP2022125213A/en active Pending 2022-08-02 CO CONC2022/0010915A patent/CO2022010915A2/en unknown 2022-08-02 CL CL2022002084A patent/CL2022002084A1/en unknown 2022-08-19 CO CONC2022/0011728A patent/CO2022011728A2/en unknown 2025 2025-01-17 US US19/026,842 patent/US20250152673A1/en active Pending 2025-10-16 JP JP2025174835A patent/JP2026009142A/en active Pending 2025-12-15 US US19/419,518 patent/US20260102471A1/en active Pending 2025-12-17 US US19/423,120 patent/US20260108587A1/en active Pending
How people actually react to GLP-1 use When GLP-1 users do open up, the response is almost always better than they feared, and often much better
MET-097i is injectable only
Tesamorelin protects lean tissue by boosting IGF-1 and enhancing protein synthesis, making it easier to maintain size while dialing in conditioning
Subcutaneous injection sites: Primary : Abdominal fat (2 inches from navel) Secondary : Upper thigh Rotation : Change sites daily to prevent tissue irritation Injection technique: Clean injection site with alcohol Pinch skin to create fold Insert needle at 45-degree angle Inject slowly and steadily Remove needle and apply gentle pressure Storage and Handling Proper storage ensures your Ipamorelin maintains potency throughout your cycle: Reconstituted peptide storage: Temperature : 36-46F (2-8C) refrigerated Duration : Use within 30 days Protection : Keep away from light and heat Handling : Minimize agitation and temperature fluctuations Lyophilized powder storage: Temperature : Room temperature or refrigerated Duration : 2+ years when properly stored Protection : Keep sealed and dry Understanding proper CJC-1295 and Ipamorelin planning and sourcing ensures you maintain peptide integrity throughout your protocol
2 to 4 days anywhere in Canada
